Skip to main content

Advertisement

SpringerLink
Log in

Vascular Endothelial Growth Factor Levels in Childhood Acute Lymphoblastic and Myeloblastic Leukemia

  • Original Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Angiogenesis has been associated with the growth, dissemination and metastasis and has been shown to be a prognostic. Although there are some data suggesting that angiogenesis may have a role in the pathophysiology of leukemia, its role in patient prognosis is yet to be defined. We analyzed the expression level of vascular endothelial growth factor (VEGF), an angiogenesis promoter and its possible- prognostic value in bone marrow samples at the time of diagnosis and remission of acute childhood leukemia patients. Besides 46 patients diagnosed as ALL or AML, 16 children were also included as a control group in the study. Our data have demonstrated that VEGF levels of AML patients were found higher than the control group statistically (P = 0.022). However we could not find any significant difference between VEGF levels of diagnosis and remission in both AML and ALL groups by blastic VEGF expression (P > 0.05). In this study the higher levels of VEGF in AML patients is one of the main findings although we were not able to assess any role of VEGF in predicting prognosis in pediatric leukemia patients by evaluating blastic cell VEGF expression. These results have demonstrated that the relationship between angiogenesis or angiogenesis promoters and hematological malignancies is not clear and simple as different methods or different cells beside different angiogenesis promotors are involved to these studies. So that not only tumor cells and their cytokines but also surrounding cells and their cytokines must be taken into consideration with the standardized study methods in the further studies to obtain a promising treatment approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Risau W, Drexler H, Mironov V et al (1992) Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7:261–266

    Article  PubMed  CAS  Google Scholar 

  2. Arnold F, West DC (1991) Angiogenesis in wound healing. Pharmacol Ther 52:407–422

    Article  PubMed  CAS  Google Scholar 

  3. Welsh AO, Enders AC (1991) Chorioallantoic placenta formation in the rat, II: angiogenesis and maternal blood circulation in the mesometrial region of the implantation chamber prior to placenta formation. Am J Anat 192:347–365

    Article  PubMed  CAS  Google Scholar 

  4. Leung DW, Cachianes G, Kuang WJ et al (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306–1309

    Article  PubMed  CAS  Google Scholar 

  5. Maeda K, Kang SM, Onoda N et al (1999) Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma. Cancer 86:566–571

    Article  PubMed  CAS  Google Scholar 

  6. Konig JE, Tolnay E, Wiethege T et al (1999) Expression of vascular endothelial growth factor in diffuse malignant pleural mesothelioma. Virchows Arch 435:8–12

    Article  PubMed  CAS  Google Scholar 

  7. Jones A, Crew J (2000) Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression. Urol Clin North Am 27:191–197

    Article  PubMed  CAS  Google Scholar 

  8. Chen CA, Cheng WF, Lee CN et al (1999) Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival. Gynecol Oncol 74:235–240

    Article  PubMed  CAS  Google Scholar 

  9. Duque JL, Loughlin KR, Adam RM et al (1999) Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urology 54:523–527

    Article  PubMed  CAS  Google Scholar 

  10. Folkman J (1995) Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333:1757

    Article  PubMed  CAS  Google Scholar 

  11. Zetter BR (1998) Angiogenesis, tumor metastasis. Annu Rev Med 49:407

    Article  PubMed  CAS  Google Scholar 

  12. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86:356–361

    Article  PubMed  CAS  Google Scholar 

  13. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J (1997) Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150:815–821

    PubMed  CAS  Google Scholar 

  14. Hussong JW, Rodgers GM, Shami PJ (2000) Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 95:309–313

    PubMed  CAS  Google Scholar 

  15. Kini AR, Kay NE, Peterson LC (2000) Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia 14:1414–1418

    Article  PubMed  CAS  Google Scholar 

  16. Aguayo A, Kantarjian H, Manshouri T et al (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 96:2240–2245

    PubMed  CAS  Google Scholar 

  17. Vacca A, Ribatti D, Iurlaro M et al (1998) Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration morphogenesis, and angiogenesis. Int J Clin Lab Res 28:55–68

    Article  PubMed  CAS  Google Scholar 

  18. Mai HQ, Zeng ZY, Zhang CQ, Feng KT, Guo X, Mo HY, Deng MQ, Min HQ, Hong MH (2006) Elevated plasma big ET-1 is associated with distant failure in patients with advanced-stagenasopharyngeal carcinoma. Cancer 106(7):1548–1553

    Article  PubMed  CAS  Google Scholar 

  19. Vazquez-Martin A, Fernandez-Real JM, Oliveras-Ferraros C, Navarrete JM, Martin-Castillo B, Del Barco S, Brunet J, Menendez JA (2009) Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patients. Int J Oncol 35(6):1369–1376

    PubMed  CAS  Google Scholar 

  20. Koomagi R, Zintl F, Sauerbrey A et al (2001) Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real time quantitative polimerase chain reaction. Clin Cancer Res 7:3381–3384

    PubMed  CAS  Google Scholar 

  21. Pule M et al (2002) Increased angiogenesis in bone marrow of children with acute lymphoblastic leukemia has no prognostic significance. Br J Haematol 118:991–998

    Article  PubMed  Google Scholar 

  22. Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci PF, Buffa R, Lambertenghi-Deliliers G, Pezzella F (1999) Angiogenesis in myelodysplastic syndromes. Br J Cancer 81:1398–1401

    Article  PubMed  CAS  Google Scholar 

  23. Aguayo A, Kantarjian Hagop M, Estey Elihu H et al (2002) Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes. Cancer 95:1923–1930

    Article  PubMed  Google Scholar 

  24. Dincaslan HU, Yavuz G, Unal E, Tacyildiz N, Ikinciogullari A, Dogu F, Guloglu D, Yuksek N, Ertem U (2010) Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients? Pediatr Hematol Oncol 27(7):503–516

    Article  PubMed  CAS  Google Scholar 

  25. Litvin C, Leong KG et al (2002) Role of microenvironment in promoting angiogenesis in acute myeloid leukemia. Am J Hematol 70:22–30

    Article  Google Scholar 

  26. Sensebe L, Deschaseaux M, Li J, Herve P, Charbord P (1997) The broad spectrum of cytokine gene expression by myoid cells from the human marrow. Stem Cells 15:133–143

    Article  PubMed  CAS  Google Scholar 

  27. Gehrke I, Gandhirajan RK, Poll-Wolbeck SJ, Hallek M, Kreuzer KA (2011) Bone marrow stromal cell-derived VEGF rather than CLL cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells. Mol Med. doi:10.2119/molmed.2010.00210. (Epub ahead of print)

  28. Ter Elst A, Ma B, Scherpen FJ, de Jonge HJ, Douwes J, Wierenga AT, Schuringa JJ, Kamps WA, de Bont ES (2011) Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia. Cancer Res 71(7):2761–2771

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Hematology Division, Gaziantep Children Hospital, Gaziantep, Turkey

    Göksel Leblebisatan

  2. Faculty of Medicine, Department of Pediatric Hematology, Çukurova University, Adana, Turkey

    Bülent Antmen, İlgen Şaşmaz & Yurdanur Kilinç

Authors
  1. Göksel Leblebisatan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bülent Antmen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. İlgen Şaşmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yurdanur Kilinç
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Göksel Leblebisatan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leblebisatan, G., Antmen, B., Şaşmaz, İ. et al. Vascular Endothelial Growth Factor Levels in Childhood Acute Lymphoblastic and Myeloblastic Leukemia. Indian J Hematol Blood Transfus 28, 24–28 (2012). https://doi.org/10.1007/s12288-011-0102-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-011-0102-2

Keywords

Search

Navigation